Management of Beta-Thalassaemia in pregnancy GTG Flashcards

1
Q

What is Thalassaemia major?

A

Homozygous for B thalassaemia
Severe transfusion dependant anaemia, normall Dx 2-6 years, growth and development may be impaired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is thalassaemia minor?

A

Heterozygous for B thalassamia - mild to moderate microcytic anaemia, no detrimental impacts on health

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical manifestations of thalassaemias

A

Anaemia – varying severity
* Skeletal deformities
* Osteoporosis
* Organomegaly
* Hypercoagulable state
* Iron overload
* Transfusion related iron overload complications; including hepatic, cardiac and endocrine dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mainstay of treatment for thalassaemia

A

Blood transfusion and iron chelation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What impact can iron overload have

A

Hepatic, cardiac and endocrine (DM, hypothyroid, hypoparathyroid)

The anterior pituitary gland is sensitive to iron overload, puberty can be delayed/incomplete, low bone mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which cause of subfertility is seen in women with thalassaemia?

A

hypogonadotropic hypogonadism – may require ovulation induction with gonadotrophins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the most common cause of death in people with thalassaemia?

A
  • Cardiac failure is cause of death in 50%.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Screening for haemoglobinopathies in UK

A

Initial Family origin screening
Red cell index check in low prevalence areas
Haemoglinopathy screen in high prevalence areas

If patient has haemoglinopathy, screening offered to partner

Screen for neonate - heel prick test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What pre-conception care should be offered to women with thalassaemia?

A

ECHO (low LVEF, CI pregnancy)
ECG
T2 Cardiac MRI (Aim T2 >20mls. If <10mls - increased risk cardiac failure)
Ferriscan or Liver T2 0 ideally iron <7mg/kg, if > 15 increase risk cardiac loading + liver USS
If DM Fructosamine < 300nmol/L and HbA1c < 43 for 3 months
Test partner
Aggressive chelation desferrioxamine
Bone density scan
Review iron chelators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If early pregnancy and EF <55% or Sx of heart failure?

A

Recommend TOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which iron chelators should be stopped? What other mediation should be stopped?

A

– deferasiroc and deferiprone should be stopped 3 months before conception

  • Stop bisphosphaonates 3 months pre-pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What medications should be started in AN period?

A

Hep B vaccination
Folic acid 5mg
If splenectomy - pen V
Consider Vit D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When can desferrioxamine be given?

A

Use 3/12 pre-pregnancy
Stop in 1st trimester
Restart at 20 weeks at low dose if high iron burden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In partner testing which conditions have high risk of serious haemoglinopathy?

A

Beta Thal
HbS
HbE
Delta Beta thalassaemia
Hb Lepore
HbO Arab
Hb Constant Spring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In partner testing which conditions have high risk of mild- moderate haemoglinopathy?

A

Hb C
Other variant haemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what proportion of transfusion dependant thalassaemia are subfertile

A

80-90%

Success with ART 80% as gondal function preserves

17
Q

How often should women with B Thal be reviewed?

A

Monthly until 28 weeks, then fortnightly

18
Q

When should women with B Thal be offered growth

A

7-9 weeks
Routine 11-14 weeks
Detailed anomaly 18-20+6
Growth USS every 4 weeks from 24 weeks

19
Q

Which women should be offer low dose desferrioxamine 4-5days a week from 20-24 week?

A

Women at high risk of cardiac decompensation

  • Cardiac T2 <10mls
  • Liver iron >15mg/g

20mg/kg/day 4-5 days per week

20
Q

Women with thalasaemia should have what additional testing?

A

Test DM
Monitor TFT
Specialist cardiac assessment at 28 weeks
Regular Hb testing aiming Hb >100

21
Q

If Thalassaemia and DM, what testing?

A

Monthly frustosamine conc
Review in JANC

22
Q

If splenectomy or platelets > 600

A

Give aspirin

23
Q

If splenectomy and platelets > 600

A

Aspirin + LMWH

24
Q

What intrapartum care?

A

No specific advice re timing of delivery
Cont CTG in labour
Input - MW, Obs, anaesthetic and game
If red cell antibody - have blood X matched
If Hb <100 cross match blood
If thal major - IV desferrioxamine 2g over 24 hours should be given during labour.
Cont CTG
Active 3rd stage

25
Q

VTE consideration PP?

A

High risk VTE
LMWH 6 days if SVD
6/52 CS

26
Q

Is breast feeding safe with desferrioxamine?

A

Yes

27
Q

If BT major and breastfeeding when to restart desferrixamine?

A

o If major + BF – restart desferrioxamine as soon as 24 hour infusion stops. Secreted in breast milk but not harmful to baby

28
Q

If BT major and no breastfeeding when to restart desferrixamine?

A

IV/Subcut desferrioxamine are continued until discharge

29
Q

Consider Thalassaemia on each system

A

Pituitary: Hypogondatrophic hypogonadism
Heart - cardiomytopathy
Thyroid: Hypo/hyper
Bones Osteoporosis
Pancreas DM
Liver cirrhosis
Spleen Splenectomy/hyposplenuc
Transfusion: Hepatitis/HIV/antibdoies
Vaccine
5mg Folic acid